Junichi Matsubara
Papers
1
Total Citations
35
H-Index
1
About
Dr. Junichi Matsubara is a leading figure in pancreatic cancer research, with a focus on predictive biomarkers and personalized therapy. His most influential work, "Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment" (2010, 35 citations), addresses a critical clinical challenge: the variable response to gemcitabine monotherapy, the former standard of care for advanced pancreatic cancer. Recognizing that many patients derive little benefit from this treatment, Matsubara pioneered the use of liquid chromatography-mass spectrometry (LC-MS) to identify novel serum biomarkers capable of predicting overall survival. This foundational study laid the groundwork for more tailored treatment strategies, aiming to spare non-responders from ineffective therapies while guiding more aggressive interventions for those likely to benefit. His contributions are vital to the shift from a one-size-fits-all approach to precision oncology in one of the deadliest cancers. By integrating advanced proteomics with clinical outcomes, Matsubara’s work continues to inform the design of biomarker-driven clinical trials, offering hope for improved survival rates and quality of life for pancreatic cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1